Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.


Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?


Please Try Again {{ error }}

Send my password

An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Replicel Life Sciences Inc V.RP

Alternate Symbol(s):  REPCF

RepliCel Life Sciences Inc is a Canadian regenerative medicine company. It focuses on developing autologous cell therapies that treat functional cellular deficits. The company addresses various diseases such as chronic tendon injuries, androgenetic alopecia, and skin aging. Its development program of the company is based on distinct technology that utilizes cells isolated from a patient's healthy hair follicles. Also, the company develops a programmable cell injector device designed for dermal injections of cells, dermal filler products, and a variety of other products injected through the skin. The treatments delivered by the company use autologous cell therapy which is developed for the treatment of androgenetic alopecia. The revenue is generated from Licensing fees.

The Power Play by The Market Herald
< Previous Video {{moreVideoText}} Next Video >

Stock Price Chart (TSXV:RP)

Fundamentals Snapshot (TSXV:RP)

Bullboard Posts (TSXV:RP)

MCTO vs Private Placement

Replicel Insiders are presently under a MCTO until the 2021 financials are submitted no later than June 30th.  Therefore they cannot...
Ingiboy - 2 days ago

A Few Buyers Today

Always encouraging to see a few buyers show up.  Possibly there is some speculation that once the 2021 financials are submitted...
Ingiboy - 2 days ago

RE:RE:Private Placement

All of their patents must be worth a good chunck of change    hoping for $5+
Genie29j - 4 days ago

RE:Private Placement

 This is ripe for a hostel takeover !   I ment hostile (autocorrect).
Ingiboy - 4 days ago

Private Placement

From Stockwatch June 7th: "On May 4, 2022, the company closed a first tranche of the offering pursuant to which it sold an aggregate...
Ingiboy - 4 days ago

What's Next

This from Stockwatch June 15th RepliCel expects to file 2021 financials by June 30 RepliCel Life Sciences Inc. is providing a default...
Ingiboy - 5 days ago